Viral load in COVID-19 patients: implications for prognosis and vaccine efficacy in the context of emerging SARS-CoV-2 variants

da Silva, S. J. R., de Lima, S. C., da Silva, R. C., Kohl, A. and Pena, L. (2022) Viral load in COVID-19 patients: implications for prognosis and vaccine efficacy in the context of emerging SARS-CoV-2 variants. Frontiers in Medicine, 8, 836826. (doi: 10.3389/fmed.2021.836826) (PMID:35174189) (PMCID:PMC8841511)

[img] Text
262395.pdf - Published Version
Available under License Creative Commons Attribution.

736kB

Abstract

The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an unprecedented public health crisis in the 21st century. As the pandemic evolves, the emergence of SARS-CoV-2 has been characterized by the emergence of new variants of concern (VOCs), which resulted in a catastrophic impact on SARS-CoV-2 infection. In light of this, research groups around the world are unraveling key aspects of the associated illness, coronavirus disease 2019 (COVID-19). A cumulative body of data has indicated that the SARS-CoV-2 viral load may be a determinant of the COVID-19 severity. Here we summarize the main characteristics of the emerging variants of SARS-CoV-2, discussing their impact on viral transmissibility, viral load, disease severity, vaccine breakthrough, and lethality among COVID-19 patients. We also provide a rundown of the rapidly expanding scientific evidence from clinical studies and animal models that indicate how viral load could be linked to COVID-19 prognosis and vaccine efficacy among vaccinated individuals, highlighting the differences compared to unvaccinated individuals.

Item Type:Articles
Additional Information:The work in LP’s lab was funded by the Fiocruz Inova Program and the Foundation for Science and Technology of Pernambuco – FACEPE, Brazil (Grant No. APQ-0560-2.12/19). SS was recipient of a Ph.D. fellowship sponsored by the Foundation for Science and Technology of Pernambuco (FACEPE) Brazil, (Grant No. IBPG-1321-2.12/18). AK was supported by UK Medical Research Council (Grant No. MC_UU_12014/8).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Kohl, Professor Alain
Authors: da Silva, S. J. R., de Lima, S. C., da Silva, R. C., Kohl, A., and Pena, L.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research
Journal Name:Frontiers in Medicine
Publisher:Frontiers Media
ISSN:2296-858X
ISSN (Online):2296-858X
Copyright Holders:Copyright © 2022 Silva, Lima, Silva, Kohl and Pena
First Published:First published in Frontiers in Medicine 8: 836826
Publisher Policy:Reproduced under a Creative Commons licence

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
Arthropod-borne infections and emerging virus infections in high risk areas (Programme 4)Medical Research Council (MRC)UNSPECIFIED